Legacy Capital Wealth Management »

Adaptimmune Therapeutics shares owned by Legacy Capital Wealth Management

Quarter-by-quarter ownership of Adaptimmune Therapeutics (ADAP) shares owned by Legacy Capital Wealth Management from 13F filings

Historical chart of Legacy Capital Wealth Management investment in Adaptimmune Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adaptimmune Therapeutics held by Legacy Capital Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptimmune Therapeutics by Legacy Capital Wealth Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $15k 27k 0.54

More positions owned by Legacy Capital Wealth Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Exch Traded Fd Tr Ii Nasdaq 100 Etf (QQQM)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Pacer Fds Tr Us Cash Cows 100 (COWZ)
Capital Group Gbl Growth Eqt Shs Creation Uni (CGGO)
Apple (AAPL)
Royal Caribbean Cruises (RCL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Sterling Construction Company (STRL)
Meta Platforms Cl A (META)
S&p Global (SPGI)
Arista Networks Com Shs (ANET)

View all positions for Legacy Capital Wealth Management

Top funds holding Adaptimmune Therapeutics

Long Focus Capital Management
UBS Group
Morgan Stanley
Renaissance Technologies
Jane Street
Acadian Asset Management
Empirical Finance
National Asset Management
Rathbones Brothers
FMR
Susquehanna International
Citadel Advisors
Lumbard Investment Counseling
Lakeridge Wealth Management
XTX Topco

View all funds holding Adaptimmune Therapeutics